Cargando…

Antitumor Effect of the Tyrosine Kinase Inhibitor Nilotinib on Gastrointestinal Stromal Tumor (GIST) and Imatinib-Resistant GIST Cells

Despite the benefits of imatinib for treating gastrointestinal stromal tumors (GIST), the prognosis for high risk GIST and imatinib-resistant (IR) GIST remains poor. The mechanisms of imatinib resistance have not yet been fully clarified. The aim of the study was to establish imatinib-resistant cell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sako, Hiroyuki, Fukuda, Kazumasa, Saikawa, Yoshiro, Nakamura, Rieko, Takahashi, Tsunehiro, Wada, Norihito, Kawakubo, Hirohumi, Takeuchi, Hiroya, Ohmori, Tai, Kitagawa, Yuko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164645/ https://www.ncbi.nlm.nih.gov/pubmed/25221952 http://dx.doi.org/10.1371/journal.pone.0107613

Ejemplares similares

Antitumor effect of cetuximab in combination with S-1 in EGFR-amplified gastric cancer cells
por: FUKUDA, KAZUMASA, et al.
Publicado: (2011)

Evaluation of nilotinib in advanced GIST previously treated with imatinib and sunitinib
por: Cauchi, C., et al.
Publicado: (2011)

CC-Chemokine receptor CCR7: a key molecule for lymph node metastasis in esophageal squamous cell carcinoma
por: Irino, Tomoyuki, et al.
Publicado: (2014)

Comprehensive screening of genes resistant to an anticancer drug in esophageal squamous cell carcinoma
por: TSUTSUI, MAI, et al.
Publicado: (2015)

CXCL12 expression promotes esophageal squamous cell carcinoma proliferation and worsens the prognosis
por: Uchi, Yusuke, et al.
Publicado: (2016)

Salvage endoscopic resection as a treatment for locoregional failure or recurrence following chemoradiotherapy or radiotherapy for esophageal cancer
por: NAKAMURA, RIEKO, et al.
Publicado: (2016)

Reintroduction of Imatinib in GIST
por: Reid, T.
Publicado: (2013)

CXCR2 expression and postoperative complications affect long-term survival in patients with esophageal cancer
por: Nishi, Tomohiko, et al.
Publicado: (2015)

Intra-abdominal desmoid tumor mimicking gastric cancer recurrence: a case report
por: Okamura, Akihiko, et al.
Publicado: (2014)

Experimental and clinicopathological analysis of HOXB9 in gastric cancer
por: Kato, Fumihiko, et al.
Publicado: (2019)

Imatinib treatment for gastrointestinal stromal tumour (GIST)
por: Lopes, Lisandro F, et al.
Publicado: (2010)

Clinical outcome of transthoracic esophagectomy with thoracic duct resection: Number of dissected lymph node and distribution of lymph node metastasis around the thoracic duct
por: Matsuda, Satoru, et al.
Publicado: (2016)

A Highly Advanced Gastric Cancer Maintaining a Clinical Complete Response after Chemoradiotherapy Comprising S-1 and Cisplatin
por: Yura, Masahiro, et al.
Publicado: (2018)

Improved Efficacy of First-Line Imatinib in Advanced Gastrointestinal Stromal Tumors (GIST): The Dutch GIST Registry Data
por: Mohammadi, Mahmoud, et al.
Publicado: (2023)

A case of late lymph node metastasis after three endoscopic mucosal resections of intramucosal gastric cancers
por: Booka, Eisuke, et al.
Publicado: (2014)

Correction: phase I study of neoadjuvant chemoradiotherapy with S-1 plus biweekly cisplatin for advanced gastric cancer patients with lymph node metastasis -KOGC04-
por: Matsuda, Satoru, et al.
Publicado: (2014)

Phase I study of neoadjuvant chemoradiotherapy with S-1 plus biweekly cisplatin for advanced gastric cancer patients with lymph node metastasis: -KOGC04-
por: Matsuda, Satoru, et al.
Publicado: (2014)

A GIST or not a GIST? That is the question
por: Chrysanthos, Nikolaos, et al.
Publicado: (2014)

High‐risk group of upper and middle mediastinal lymph node metastasis in patients with esophagogastric junction carcinoma
por: Yura, Masahiro, et al.
Publicado: (2018)

Metastatic duodenal GIST: role of surgery combined with imatinib mesylate
por: Mohiuddin, Kamran, et al.
Publicado: (2007)

Imatinib plasma levels: correlation with clinical benefit in GIST patients
por: Widmer, N, et al.
Publicado: (2010)

Update on the treatment of gastrointestinal stromal tumors (GISTs): role of imatinib
por: Quek, Richard, et al.
Publicado: (2010)

Novel receptor tyrosine kinase targeted combination therapies for imatinib-resistant gastrointestinal stromal tumors (GIST)
por: Mahadevan, Daruka, et al.
Publicado: (2014)

The Impact of Postoperative Complications on Survivals After Esophagectomy for Esophageal Cancer
por: Booka, Eisuke, et al.
Publicado: (2015)

Synchronous double gastric tumors: GIST or not GIST
por: Sayida, Sa’d, et al.
Publicado: (2020)

Prognostic impact of thoracic duct lymph node metastasis in esophageal squamous cell carcinoma
por: Matsuda, Satoru, et al.
Publicado: (2021)

Tumor Volume as an Alternative Response Measurement for Imatinib Treated GIST Patients
por: Schiavon, Gaia, et al.
Publicado: (2012)

Subcapsular Liver Hematoma in Metastatic GIST Complicating Imatinib (Gleevec) Therapy
por: Shankar, Sridhar
Publicado: (2015)

Imatinib-induced Ototoxicity in a Patient with Gastrointestinal Stromal Tumor (GIST)
por: Wasif, Komal, et al.
Publicado: (2016)

Can therapeutic drug monitoring increase the safety of Imatinib in GIST patients?
por: Zhuang, Wei, et al.
Publicado: (2018)

Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST)
por: Tang, Sumin, et al.
Publicado: (2017)

GIST and Ghrelin: To Be or Not to Be?
por: Spiridon, Irene Alexandra, et al.
Publicado: (2021)

Imatinib administration in two patients with liver metastases from GIST and severe jaundice
por: De Pas, T, et al.
Publicado: (2003)

Role of imatinib in the management of early, operable, and advanced GI stromal tumors (GISTs)
por: Vetto, John T
Publicado: (2009)

Correction: Tumor Volume as an Alternative Response Measurement for Imatinib Treated GIST Patients
por: Schiavon, Gaia, et al.
Publicado: (2013)

Multimodal functional imaging for early response assessment in GIST patients treated with imatinib
por: Revheim, Mona-Elisabeth, et al.
Publicado: (2014)

Rapidly progressive dyspnea in gastrointestinal stromal tumor (GIST) with imatinib cardiac toxicity
por: Ghias, Adnan Asif Parvez, et al.
Publicado: (2018)

Association of anastomotic leakage with long-term oncologic outcomes of patients with esophagogastric junction cancer
por: Takeuchi, Masashi, et al.
Publicado: (2022)

Fistulizing Gastric GIST
por: Costa, Mariana, et al.
Publicado: (2015)

Long-Surviving Patients with Recurrent GIST after Receiving Cytoreductive Surgery with Imatinib Therapy
por: Choi, Won Hyuk, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_clpf3ogbvkhvqbadlq4uut2oap